(R)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione manufacturers
- Exatecan Impurity
-
-
2025-12-16
- CAS:110351-91-2
- Min. Order: 10mg
- Purity: 99%+ HPLC
- Supply Ability: 1000
|
| | (R)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione Basic information |
| Product Name: | (R)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione | | Synonyms: | (R)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione;5'(R)-1,5-dioxo-5'-ethyl-5'-hydroxy-2'H,5'H,6'H-6'-oxopyrano<3',4'-f>Δ6,8-tetrahydroindolizine;1H-Pyrano[3,4-f]indolizine-3,6,10(4H)-trione, 4-ethyl-7,8-dihydro-4-hydroxy-, (R)- (9CI);(4R)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione;(R)-Exatecan Intermediate 1;(R)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione , (R)-Exatecan Intermediate 1;(4R)-4-ethyl-4-hydroxy-1H,3H,4H,6H,7H,8H,10H-pyrano[3,4-f]indolizine-3,6,10-trione | | CAS: | 110351-91-2 | | MF: | C13H13NO5 | | MW: | 263.25 | | EINECS: | | | Product Categories: | 1 | | Mol File: | 110351-91-2.mol | ![(R)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione Structure](CAS/GIF/110351-91-2.gif) |
| | (R)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione Chemical Properties |
| Melting point | 169-170 °C(Solv: ethyl acetate (141-78-6)) | | Boiling point | 666.6±55.0 °C(Predicted) | | density | 1.50±0.1 g/cm3(Predicted) | | pka | 11.20±0.20(Predicted) | | form | Solid | | color | Light yellow to light brown |
| | (R)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione Usage And Synthesis |
| Uses | (R)-Exatecan Intermediate 1 is an isomer of Exatecan Intermediate 1 (HY-42487). Exatecan Intermediate 1 (compound 6) is an intermediate of Exatecan (HY-13631), a camptothecin-based anticancer agent. Exatecan inhibits tumor growth by interfering with the proliferation and division of tumor cells by interacting with DNA. Exatecan is primarily used in research into a variety of cancers including ovarian, lung and breast cancer[1][2]. | | IC 50 | Camptothecins |
| | (R)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione Preparation Products And Raw materials |
|